A multivariable analysis suggested the safety and efficacy of onasemnogene abeparvovec (OA) in the treatment of older and heavier children with spinal muscular atrophy (SMA) type 1.
Spinraza benefits SMA children not helped by Zolgensma: Interim data smanewstoday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from smanewstoday.com Daily Mail and Mail on Sunday newspapers.
Current treatments improve motor function in SMA type 1 children across Spain | Study examines effects of current SMA therapies on 51 children in Spain smanewstoday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from smanewstoday.com Daily Mail and Mail on Sunday newspapers.
An update on the emerging evidence of the effects and safety of disease modifying therapies for the management of children with spinal muscular atrophy (SMA).